Skip to content

Effect of high dose tranexamic acid versus standard dose of tranexamic acid to decrease blood loss in spine surgeries

Comparison of the effect of tranexamic acid- high verses standard dose upon intraoperative and postoperative blood loss in patients undergoing open Spine surgery -A Double blinded randomized control trial. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082166
Enrollment
76
Registered
2025-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: patients in the group received high dose iv tranexamic acid: patients in this group received high dose tranexamic acid (50mg/kg) Control Intervention1: patients in the group received st

Sponsors

AIIMS Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Skeletally mature patients with preop hemoglobin more than 10 mg/dl with vertebral fractures, degenerative disc diseases, spondylodiscitis who needs open spine surgery. 2.People with normal levels of PT with INR and Aptt levels

Exclusion criteria

Exclusion criteria: 1.Elevated PT, PTT, INR for any reason 2.Patients with cervical disc disease and cervical vertebral fracture who needs anterior cervical diskectomy and fusion. 3.Patients who need single level lumbar diskectomy, single level spine decompression for lumbar canal stenosis. 4.Patients with pathological fractures, intradural tumor and spine deformity 5.History of thrombotic events such as CVA and MI 6.History of bleeding disorder 7.History of traumatic brain injury and CPR 8.Cancer, or any other serious illness that affects treatment evaluation 9.Renal failure with GFR lower than 60 ml/min 10.Use of anticoagulants such as aspirin and dipyridamole 11.OCP consumption, pregnancy, or lactation 12.Revision spine surgery 13.Patient with intraoperative Dural tears

Design outcomes

Primary

MeasureTime frame
1.Blood loss intraoperatively 2.Blood loss postoperatively Timepoint: 1.Intraoperatively 2.Postoperatively

Secondary

MeasureTime frame
1.The complications associated with the use of Tranexamic acid in spine surgery. 2.Relation between TXA dosage with hospital stay. Timepoint: 1. Intraoperative 2. Postoperative

Countries

India

Contacts

Public ContactPrabhat Agrawal

AIIMS PATNA

drprabhatagrawal@gmail.com9811663869

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026